Is Hyaluronidase Able to Reverse Embolism Associated with Hyaluronic Acid Filler? An Anatomical Case Study
Accepted: Oct 2019 Journal of Biological Regulators & Homeostatic Agents.
COPYRIGHT
NYUMA PHARMA® s.r.l – Vat number / FC: 02595180031 – NO-245952 – Social Capital: € 10.000,00 i.v. – Office: Street San Carlo, 56 – 28041 – Arona (NO) – ITALY – Pec: nyumapharma@pec.it – Phone +39 0322.600623. The company is not in a state of liquidation, is not a single member and is not subject to coordination by other bodies or companies.
NYUMA PHARMA® s.r.l is not connected directly or indirectly to companies, all brands and logos belong to their respective owners.